FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rabea Asleh

Research Profile

Chemicals & Drugs

Physiology

Disorders

Phenomena

Oxidation-Reduction

Living Beings

Co-author Network

Publications

TOP 3
Rabea Asleh; Hoda Awad; Dan Farbstein; Theodore C Iancu; Michael Laue; Katie M Lebold; Nina S Levy; Irena Manov; Rachel Miller-Lotan; Farid Nakhoul; Nakhoul Nakhoul; Maret G Traber; Andrew P Levy
Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.
Dan Farbstein; Shiri Kalet-Littman; Orit Lache; Arie Laor; Nur Abbas; Y Anbinder; Roy Asaf; Rabea Asleh; Ido Barkay; Shany Blum; Stephen E Bucher; Yishai Levy; Rachel Miller-Lotan; Doron Moskovich; David Ozeri; Netta Perry; Mordechai Pollak; Avery Schwartz; Michael Star; Hagai Tavori; Moshe Vardi; Jacob Vaya; Hilla Lee Viener; Andrew P Levy
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.
Rabea Asleh; Andrew P Levy; Shany Blum
Cholesterol efflux capacity and atherosclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rabea Asleh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rabea Asleh; Hoda Awad; Dan Farbstein; Theodore C Iancu; Michael Laue; Katie M Lebold; Nina S Levy; Irena Manov; Rachel Miller-Lotan; Farid Nakhoul; Nakhoul Nakhoul; Maret G Traber; Andrew P Levy
Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.
Free radical biology & medicine 2012;53(4):779-86.
2011: Dan Farbstein; Shiri Kalet-Littman; Orit Lache; Arie Laor; Nur Abbas; Y Anbinder; Roy Asaf; Rabea Asleh; Ido Barkay; Shany Blum; Stephen E Bucher; Yishai Levy; Rachel Miller-Lotan; Doron Moskovich; David Ozeri; Netta Perry; Mordechai Pollak; Avery Schwartz; Michael Star; Hagai Tavori; Moshe Vardi; Jacob Vaya; Hilla Lee Viener; Andrew P Levy
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.
Atherosclerosis 2011;219(1):240-4.
2011: Rabea Asleh; Andrew P Levy; Shany Blum
Cholesterol efflux capacity and atherosclerosis.
The New England journal of medicine 2011;364(15):1473; author reply 1474-5.
2010: Shany Blum; Moshe Vardi; Jonathan B. Brown; Allen Russell; Uzi Milman; Chen Shapira; Nina S Levy; Rachel Miller-Lotan; Rabea Asleh; Andrew P Levy
Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.
Pharmacogenomics 2010;11(5):675-84.
2010: Rabea Asleh; Andrew P Levy
Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype.
Antioxidants & redox signaling 2010;12(2):209-17.
2010: Andrew P Levy; Rabea Asleh; Shany Blum; Nina S Levy; Rachel Miller-Lotan; Shiri Kalet-Litman; Y Anbinder; Orit Lache; Farid Nakhoul; Roy Asaf; Dan Farbstein; Mordechai Pollak; Yitzhak Z Soloveichik; Merav Strauss; Jonia Alshiek; Alina Livshits; Avery Schwartz; Hoda Awad; Kheir Jad; Hagit Goldenstein
Haptoglobin: basic and clinical aspects.
Antioxidants & redox signaling 2010;12(2):293-304.
2009: Farid Nakhoul; Rachel Miller-Lotan; Hoda Awad; Rabea Asleh; Kheir Jad; Nakhoul Nakhoul; Roy Asaf; Niroz Abu-Saleh; Andrew P Levy
Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
American journal of physiology. Renal physiology 2009;296(4):F830-8.
2009: Avery Schwartz; Mordechai Pollak; Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Andrew P Levy
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction.
Pharmacogenomics and personalized medicine 2009;2():1-8.
2008: Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Jonia Alshiek; Rachel Miller-Lotan; Roy Asaf; Wasseem Rock; Michael Aviram; Uzi Milman; Chen Shapira; Zaid Abassi; Andrew P Levy
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Diabetes 2008;57(10):2794-800.
2007: Andrew P Levy; K Raman Purushothaman; Nina S Levy; Meerarani Purushothaman; Merav Strauss; Rabea Asleh; Stuart Marsh; Osher Cohen; Søren K Moestrup; Holger J Moller; Elias Zias; Daniel Benhayon; Valentin Fuster; Pedro R Moreno
Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.
Circulation research 2007;101(1):106-10.
2007: Farid Nakhoul; Rachel Miller-Lotan; Huda Awaad; Rabea Asleh; Andrew P Levy
Hypothesis--haptoglobin genotype and diabetic nephropathy.
Nature clinical practice. Nephrology 2007;3(6):339-44.
2007: Shany Blum; Roy Asaf; Julia Guetta; Rachel Miller-Lotan; Rabea Asleh; Ran Kremer; Nina S Levy; Franklin G Berger; Doron Aronson; Xiaoming Fu; Renliang Zhang; Stanley L Hazen; Andrew P Levy
Haptoglobin genotype determines myocardial infarct size in diabetic mice.
Journal of the American College of Cardiology 2007;49(1):82-7.
2006: Rabea Asleh; Rachel Miller-Lotan; Michael Aviram; Tony Hayek; Michael Yulish; Joanne E Levy; Benjamin Miller; Shany Blum; Uzi Milman; Chen Shapira; Andrew P Levy
Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.
Circulation research 2006;99(12):1419-25.
2005: Mahmoud Suleiman; Doron Aronson; Rabea Asleh; Michael Kapeliovich; Ariel Roguin; Simcha R Meisel; Michael Shochat; Abeer Sulieman; Shimon A Reisner; Walter Markiewicz; Haim Hammerman; Rachel Lotan; Nina S Levy; Andrew P Levy
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.
Diabetes 2005;54(9):2802-6.
2005: Rabea Asleh; Julia Guetta; Shiri Kalet-Litman; Rachel Miller-Lotan; Andrew P Levy
Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.
Circulation research 2005;96(4):435-41.
2005: Rabea Asleh; Andrew P Levy
In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
Vascular health and risk management 2005;1(1):19-28.
2004: Mahmoud Sulieman; Rabea Asleh; Zvi I Cabantchik; William Breuer; Doron Aronson; Abeer Suleiman; Rachel Miller-Lotan; Haim Hammerman; Andrew P Levy
Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes.
Diabetes care 2004;27(11):2730-2.
2003: Mark Shilkrut; Gal Yaniv; Rabea Asleh; Andrew P Levy; Sarit Larisch; Ofer Binah
Tyrosine kinases inhibitors block Fas-mediated deleterious effects in normoxic and hypoxic ventricular myocytes.
Journal of molecular and cellular cardiology 2003;35(10):1229-40.
2003: Rabea Asleh; Stuart Marsh; Mark Shilkrut; Ofer Binah; Julia Guetta; Flavio Lejbkowicz; Benjamin I Enav; Naim Shehadeh; Yoram Kanter; Orit Lache; Osher Cohen; Nina S Levy; Andrew P Levy
Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
Circulation research 2003;92(11):1193-200.